glucose sterop 300 mg/ml inf. sol. i.v. amp.
laboratoires sterop sa-nv - glucose monohydrate 330 mg/ml - eq. glucose anhydrous 300 mg/ml - solution for infusion - 300 mg/ml - glucose monohydrate 330 mg/ml - carbohydrates
glucose sterop 500 mg/ml inf. sol. i.v. amp.
laboratoires sterop sa-nv - glucose monohydrate 550 mg/ml - eq. glucose anhydrous 500 mg/ml - solution for infusion - 500 mg/ml - glucose monohydrate 550 mg/ml - carbohydrates
glucose sterop 200 mg/ml inf. sol. i.v. amp.
laboratoires sterop sa-nv - glucose monohydrate 220 mg/ml - eq. glucose anhydrous 200 mg/ml - solution for infusion - 200 mg/ml - glucose monohydrate 220 mg/ml - carbohydrates
glucose sterop 300 mg/ml inf. sol. i.v. amp.
laboratoires sterop sa-nv - glucose monohydrate 330 mg/ml - eq. glucose anhydrous 300 mg/ml - solution for infusion - 300 mg/ml - glucose monohydrate 330 mg/ml - carbohydrates
glucose sterop 500 mg/ml inf. sol. i.v. amp.
laboratoires sterop sa-nv - glucose monohydrate 550 mg/ml - eq. glucose anhydrous 500 mg/ml - solution for infusion - 500 mg/ml - glucose monohydrate 550 mg/ml - carbohydrates
glucose sterop 500 mg/ml inf. sol. i.v. vial
laboratoires sterop sa-nv - glucose monohydrate 550 mg/ml - eq. glucose anhydrous 500 mg/ml - solution for infusion - 500 mg/ml - glucose monohydrate 550 mg/ml - carbohydrates
glucose sterop 50 mg/ml parent. solv. i.v. amp.
laboratoires sterop sa-nv - glucose monohydrate 55 mg/ml - eq. glucose anhydrous 50 mg/ml - solution for infusion - 50 mg/ml - glucose monohydrate 55 mg/ml - other alimentary tract and metabolism products
glucose 50 %
lapidot medical import and marketing ltd - glucose as monohydrate - concentrate for solution for infusion - glucose as monohydrate 50 % - glucose - glucose - high caloric carbohydrate infusion hypoglycaemia.
glucose 20 %
lapidot medical import and marketing ltd - glucose as monohydrate - solution for infusion - glucose as monohydrate 20 % - glucose - glucose - high caloric carbohydrate infusion hypoglycaemia.
glucose injection (baxter)
baxter healthcare ltd - glucose monohydrate 10% - solution for infusion - 10 % - active: glucose monohydrate 10% - hypertonic infusion solutions are indicated: - as a source of energy incorporated with parenteral nutrition with minimal dilution effect - for use with an appropriate protein (nitrogen) source in the prevention of nitrogen loss or in the treatment of negative nitrogen balance in patients where: a) the alimentary tract cannot or should not be used b) gastrointestinal absorption of protein is impaired c) metabolic requirements for protein are substantially increased, as with extensive burns.